ESAB
ESAB's revenue rose 3.7% to $2.8 billion in fiscal 2025. Its operating margin was 14.5%, down from 16.3% a year earlier. Free cash flow was $213 million, down 29.8%. It paid out $22 million in dividends and buybacks, 10% of free cash flow. The diluted share count rose 0.3%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2020 to 2025, earnings per share grew 7.0% a year and net income 7.6% a year, as new shares raised the share count by 2% and diluted each share's earnings.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value ESAB yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from ESAB's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from ESAB's fiscal 2025 free cash flow of $213M, net cash of −$1.0B at December 31, 2025 and 61 million diluted shares, from its filings. The scenarios are fitted to ESAB: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 3.1% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 10%: 9% for a business of moderate risk (Industrial Machinery & Supplies & Components), plus 1 point as a smaller company, worth $4.1B; the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $67.31
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from ESAB's earnings per share of $2.78 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 26.7×, the middle of ESAB's own P/E today, its peers' median and its sector's median (the Industrials median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 11%, 10% and 9%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $67.31
- Value at this multiple, against the last close
- —
- ESAB's P/E at the last close
- 24.2×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| IDEXIEX | $231.06 | $6.95 | 33.2× |
| NordsonNDSN | $321.98 | $9.88 | 32.6× |
| Carpenter TechnologyCRS | $289.48 | $11.34 | 25.5× |
| ESABESAB | $67.31 | $2.78 | 24.2× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 41 | 72 | 102 | 249 | 186 |
| Debt incl. finance leases | 0 | 1,219 | 1,018 | 1,076 | 1,235 |
| Net debt (negative means net cash) | −41 | 1,147 | 916 | 826 | 1,049 |
| Net debt to EBITDA | −0.1x | 2.9x | 1.9x | 1.6x | 2.1x |
| Debt to equity | 0.0x | 0.9x | 0.6x | 0.6x | 0.6x |
| Interest coverage | — | 9.5x | 5.1x | 7.2x | 6.2x |
| Current ratio | 1.6x | 1.6x | 1.6x | 1.8x | 1.9x |
| Quick ratio | 0.9x | 0.9x | 1.0x | 1.2x | 1.2x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought ESAB shares on the open market, and 5 insiders sold $8.9 million, $8.4 million of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Rhonda L JordanDirector | Sold | 1,000 | $95.00 | $95,000 | Form 4 |
| Feb 27, 2026 | Michele CampionChief Human Resources Officer | Sold plan | 5,096 | $122.63 | $624,922 | Form 4 |
| Feb 23, 2026 | Shyam KambeyandaPresident and CEO, Director | Sold plan | 59,404 | $123.79 | $7.4 million | Form 4 |
| Feb 6, 2026 | Kevin J JohnsonChief Financial Officer | Sold plan | 3,494 | $134.62 | $470,362 | Form 4 |
| Nov 11, 2025 | Rajiv VinnakotaDirector | Sold | 2,783 | $114.50 | $318,654 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Fail |
| Current ratio rose | Fail | Pass | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Pass | Fail |
| Revenue rose relative to assets | Fail | Fail | Fail |
| F-score | 5 of 9 | 6 of 9 | 4 of 9 |
| Accruals ratio | −3.3% | −2.3% | −0.8% |
Compare
Put ESAB side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| ESAB | FY25 | 3.7% | 14.5% | 7.5% | 11.0% | 2.1x | 4 | |
| Nordson | FY25 | 3.8% | 25.5% | 23.7% | 11.6% | 2.4x | 5 | Compare |
| Carpenter Technology | FY26 | 8.6% | 22.5% | 11.6% | 23.7% | 0.3x | 9 | Compare |
| Middleby | FY25 | 1.6% | 18.0% | 17.5% | 8.7% | 2.9x | 4 | Compare |
| IDEX | FY25 | 5.8% | 20.2% | 17.8% | 10.2% | 1.4x | 7 | Compare |
6 years of figures
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 1,950 | 2,428 | 2,594 | 2,775 | 2,741 | 2,843 |
| Revenue growth | — | 24.5% | 6.8% | 7.0% | −1.2% | 3.7% |
| Gross profit | 682 | 838 | 886 | 1,016 | 1,038 | 1,048 |
| Research and development | 35 | 40 | 36 | 39 | 39 | 44 |
| Operating income | 202 | 306 | 329 | 404 | 447 | 412 |
| Net income | 157 | 235 | 224 | 205 | 265 | 227 |
| Diluted EPS (US$) | 2.62 | 3.92 | 3.69 | 3.36 | 4.31 | 3.67 |
| Diluted shares (millions) | 60 | 60 | 60 | 61 | 61 | 61 |
| Cash flow | ||||||
| Cash from operations | 309 | 251 | 214 | 330 | 355 | 261 |
| Capital expenditure | 40 | 36 | 40 | 48 | 52 | 47 |
| Free cash flow | 269 | 215 | 174 | 282 | 304 | 213 |
| Dividends paid | 0 | 0 | 6 | 13 | 17 | 22 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 5 | 149 | 19 | 154 | 438 |
| Stock-based compensation | 6 | 6 | 13 | 16 | 20 | 17 |
| Balance sheet at fiscal year end | ||||||
| Cash and short-term investments | 49 | 41 | 72 | 102 | 249 | 186 |
| Debt incl. finance leases | — | 0 | 1,219 | 1,018 | 1,076 | 1,235 |
| Total assets | — | 3,461 | 3,754 | 3,829 | 4,034 | 4,766 |
| Total liabilities | — | 960 | 2,366 | 2,181 | 2,226 | 2,555 |
| Shareholders' equity | 2,545 | 2,461 | 1,350 | 1,607 | 1,769 | 2,166 |
| Margins and ratios | ||||||
| Gross margin | 35.0% | 34.5% | 34.1% | 36.6% | 37.9% | 36.9% |
| Operating margin | 10.4% | 12.6% | 12.7% | 14.6% | 16.3% | 14.5% |
| Net margin | 8.1% | 9.7% | 8.6% | 7.4% | 9.7% | 8.0% |
| Free cash flow margin | 13.8% | 8.9% | 6.7% | 10.2% | 11.1% | 7.5% |
| Return on capital | — | — | 10.1% | 11.1% | 13.6% | 11.0% |
| Return on equity | — | — | 11.7% | 13.9% | 15.7% | 11.5% |
| Return on assets | — | — | 6.2% | 5.4% | 6.7% | 5.2% |
| Net debt to EBITDA | — | −0.1x | 2.9x | 1.9x | 1.6x | 2.1x |